Clinical Trials Directory

Trials / Completed

CompletedNCT05696938

Improved Skin Whitening Outcomes Associated With Nicotinamide Fortified Consumption in 30 to 50- Year-old Women

Improved Skin Whitening Outcomes Associated With Nicotinamide Fortified Consumption in 30 to 50-Year-old Women, a Double Blind, Control and Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Shenzhen Precision Health Food Technology Co. Ltd., · Other Government
Sex
Female
Age
30 Years – 50 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to study whether the products with nicotinamide fortified could improve skin whitening in 30 to 50-year-old women. Partipants will be randomly assigned to two study groups and use products (study product plus nicotinamide supplement and placebo product without nicotinamide supplement) for 2 months, twice a day. Researchers will compare the two groups whether there are significant improvement in skin whitening via skin measurement and analysis systems.

Detailed description

This study is two arms, randomized, double-blind controlled trial. 70 eligible partipants at two study sites will be enrolled and use randomly assigned products (study product plus nicotinamide supplement and placebo product) for 2 months. Participants will visit the study site for three times on baseline day, day 30, and day 60, all relevant data will be captured, measured via professional skin equipment system and recorded in the data management system. At the end of study, the explantory and statisitcal analysis will be conducted to validate the assumption that the using products with nicotinamide fortified could improve skin whitening in 30 to 50-year-old women.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWonderlab Nicotinamide DrinkParticipants in this arm will use a bottle of 25ml each time, twice a day, for 2 months.
DIETARY_SUPPLEMENTOrdinary DrinkParticipants in this arm will use a bottle of 25ml each time, twice a day, for 2 months.

Timeline

Start date
2023-02-16
Primary completion
2023-04-26
Completion
2023-04-26
First posted
2023-01-25
Last updated
2023-11-24

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05696938. Inclusion in this directory is not an endorsement.